Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase-1 Study Comparing the Pharmacokinetics of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function

NCT02775981 is registered in ClinicalTrials.gov with Pharmaceutical Project Solutions, Inc. as lead sponsor.

NCT NCT02775981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02775981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase-1 Study Comparing the Pharmacokinetics of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function
Lead sponsor
Pharmaceutical Project Solutions, Inc.
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2016
Completion date
September 30, 2016
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesic allergy